Join us in the enchanting city of Barcelona, Spain, on May 09-10, 2024, for the 13th International Conference on Cardiology and Cardiovascular Medicine Research. Under the theme "Healing Hearts, Changing Lives: Cardiology's Impact on Communities," this conference promises an engaging and transformative experience.
Our event is a unique platform where top-notch cardiologists, researchers, and healthcare professionals from around the world gather to explore the latest innovations in cardiovascular medicine. Together, we will uncover groundbreaking solutions that not only heal hearts but also positively impact communities.
Expect inspiring keynote speakers, in-depth discussions, and interactive workshops that delve into the diverse facets of cardiology research and practice. We'll navigate the dynamic intersection of science, technology, and patient care, all against the backdrop of Barcelona's vibrant culture.
-
Networking Opportunities: Connect with top cardiologists, researchers, and healthcare professionals from around the world, fostering collaborations and partnerships.
-
Scientific Exchange: Participate in discussions, debates, and knowledge sharing with peers, contributing to the advancement of cardiovascular science.
-
Beautiful Setting: Enjoy the enchanting city of Barcelona, known for its rich culture, historic landmarks, and culinary delights, making the conference experience even more memorable.
-
Personal Growth: Attend workshops and sessions that promote personal growth, resilience, and well-being, ensuring a holistic conference experience.
The global cardiac biomarker diagnostic test kits market is expected to be worth US$ 2,540.8 MN in 2028, and is projected to increase at a CAGR of 5.1% through 2028. North America is expected to be a dominant market, which accounted for US$ 522.5 MN in 2017, and is expected to grow at a CAGR of 4.3%.
North America has been the dominant regional market for heart diagnostics with a share of approximately 47% of the overall heart diagnostics market in terms of revenue in 2022, followed by Europe which accounted for around 38% share in the market and then by Asia accounting for 15% share.
Governments are trying to limit hospital readmissions to reduce the prevalence of hospital acquired infections (HAIs) by imposing penalties on hospitals.
On the other hand, high device cost and stringent regulatory approval procedure are some of the prime factors challenging the growth of the market. In addition, lack of skilled professionals to perform surgical procedures using advanced devices is impeding the adoption of new devices. The global cardiac monitoring market is expected to register a CAGR of around 4%. North America accounted for the highest market value in 2022. However, Middle East & Africa is expected to register the highest CAGR during the forecast period. Cardiovascular diseases have become one of the primary reasons for mortality and are becoming a major concern in most parts of the world. Coronary heart disease (CHD) is the most common type of heart disease, with a death toll of more than 370,000 people annually. The American Heart Association (AHA) reports cardiovascular disease to be the leading global cause of death, accounting for 17.3 million deaths per year, a number that is expected to grow to more than 23.6 million by 2030. The Heart Foundation also states that CVD is a major cause of death in Australia, with 45,053 deaths attributed to CVD in the country, in 2022.
Global Cardiovascular Information System Market Size and Forecast:
The Global Cardiovascular Data system Market was valued at USD 665.27 million in 2016 and is projected to flourish in USD 1,269.09 million by 2025, growing at a CAGR of 7 .4% from 2017 to 2025.
The increasing pervasiveness of cardiovascular diseases (CVDs) is predicted to spice up the enlargement of the worldwide cardiovascular Information system Market over the forecast period. The increasing prevalence of cardiovascular diseases like cardiac failure, arrhythmias, and ischemic heart situation is that the chief driver of the worldwide Cardiovascular Information system Market. For more Click Here!
Benefits of participating @ Molecular Cardiology 2024, Barcelona, Spain
-
Access to all Scientific Sessions (Keynotes, Plenary, Workshops, Symposiums, Poster Presentations)
-
Will be felicitated with International Organizing Committee Member (IOCM) Certificate
-
Full Conference Kit with Conference Souvenir and Final Program (e-copies)
-
Abstracts will be published in the conference souvenir and respective International journals
-
Each Abstract will receive unique (DOI) Number provided by Cross Ref
-
Laudable talks by the top-notch of the Global Scientific Community
-
Website visibility to more than 35K visitors in less than 6 months
-
Keynote sessions by world’s most eminent researchers
-
One on One Meeting with Eminent Speakers
-
Top Industries Representation
-
Thought provoking Symposiums and Workshops
-
Preconference Workshops in all major countries
-
Remarkable Awards and Global Recognition to meritorious Researchers
-
Nominations for Best Poster Award
-
Outstanding Young Researcher Award geared towards best budding young research.
-
Group Registration benefits
-
Advance Research oriented presentations
-
Collaborations across Academia & Industry
-
Triumph of Awards, Certificates recognizes your commitment to your profession to encourage the nascent research.
-
A wide track of Exhibitors to showcase the new and emerging technologies.
-
Platform to Global investment community to connect with stakeholders
-
Exquisite Platform for showcasing your products and International Sponsorship
-
Best platform to develop new partnership & collaborations.
-
Best location to speed up your route into every territory in the World.
-
89% our conference attendees are the Key contact in their universities, companies, organizations, hospitals, medical centers, labs purchasing decisions.
-
Our exhibitor booths were visited 4-5 times by 80% of the attendees during the conference.
-
Past exhibitor’s feedback reveals ample of enquiries perceived from the conference attendees.
